This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

X-Change Corp. Negotiates With California Corporations For Representation And Distribution Of Phytiva Brand Line Of Products To One Of The United States' Largest Markets

DALLAS, Jan. 28, 2013 /PRNewswire/ -- X-Change Corp. (NASDAQ OTC: XCHC), a U.S. boutique company whose niche is extract-based Cosmeceutical and Nutraceuticals solutions through its Phytiva brand product line, announced today that it has been in discussions with California-based cannabis businesses for plans of a full rollout of Phytiva products to consumers in Southern California. 

The California legal cannabis market is estimated at $12 -$18 billion in total economic activity, supporting 60,000 to 110,000 jobs and $2.5 to $3.5 billion in legal, taxable wages.  The cannabis industry is a much needed windfall for the State of California which is in economic distress. Further, the industry would generate additional income and business taxes for the state. California is one of the leading states for Medical Cannabis since first legalizing in mid 1990's.

These inquiries came from conservative, well-managed firms that participate in full legal compliance through their dispensary licenses.  They have physical locations in place that will allow X-Change Corporation to market its full line of Phytiva products. 

"We are very pleased to have this opportunity to expand our product line to the patients of Southern California. With such a large population and diverse demographic, we feel current market demand already exists and will expand.   We look forward to Phytiva products helping many people in the State of California.  Hopefully, Phytiva Products will be available in the near term in the Southern California market," stated Robert Kane, President of X-Change Corp.

About Phytiva

We are among the leading experts specializing in developing all natural, organic, bio-hemp health, beauty, and cosmetic products. Our philosophy is to bring the best products possible to the entire world, to help improve and promote a healthier, natural way of life. Superior products are born from scientific data and research, and we have come to a new and innovative understanding to our product development.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,776.91 +93.33 0.53%
S&P 500 2,081.34 +12.58 0.61%
NASDAQ 4,997.4590 +5.5190 0.11%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs